Det er derfor ikke sandsynligt, at aripiprazol kan forårsage klinisk relevant lægemiddelinteraktion medieret ved disse enzymer.
Thus, aripiprazole is unlikely to cause clinically important medicinal product interactions mediated by these enzymes.